Cadrenal Therapeutics (CVKD) vs Eocene (EOCN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Eocene is the larger company by market cap ($3.7 million vs $3.5 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | CVKD | EOCN |
|---|---|---|
| Share price | $0.9723 | $3.46 |
| Market cap | $3.47M | $3.69M |
| 1-day change | -1.79% | +2.91% |
| EPS (TTM) | $-4.91 | $-15.21 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $14.50 | $12.88 |
| 52-week low | $0.85 | $3.12 |
| Distance from 52-week high | -93.29% | -73.15% |
| Average volume | 433.65K | 60.46K |
| Shares outstanding | 3.57M | 1.07M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
CVKD vs EOCN FAQ
Which is bigger, Cadrenal Therapeutics or Eocene?
Eocene (EOCN) is larger, with a market capitalization of $3.69M compared with $3.47M for Cadrenal Therapeutics (CVKD).
Are Cadrenal Therapeutics and Eocene in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.